| References |
1. Moreau C, Pautas E, Duverlie C, Berndt C, Andro M, Mahé I, Emmerich J, Lacut K, Le Gal G, Peyron I, Gouin-Thibault I, Golmard JL, Loriot MA, Siguret V. A model predicting fluindione dose requirement in elderly inpatients including genotypes, body weight, and amiodarone. Thromb Haemost. 2014 Apr 1;111(4):705-12. doi: 10.1160/TH13-07-0555. Epub 2013 Dec 12. PubMed PMID: 24337438. 2. Pautas É, Peyron I, Gouin-Thibault I, Gouronnec A, Monti A, Bouhadiba S, Badie C, Golmard JL, Siguret V. [Relationship between maintenance dosages of fluindione (Préviscan) and warfarin (Coumadin) for patients 70 years and older]. Rev Med Interne. 2015 Jan;36(1):7-9. doi: 10.1016/j.revmed.2013.11.017. Epub 2013 Dec 27. French. PubMed PMID: 24373728. 3. Peyro Saint Paul L, Martin J, Moslemi I, Le Hello C, Le Querrec A. [Warfarin switch from fluindione in elderly patients]. Presse Med. 2014 Feb;43(2):221-3. doi: 10.1016/j.lpm.2013.06.018. Epub 2013 Nov 1. French. PubMed PMID: 24184283. 4. Imbert P, Pernod G, Jacquet JP, Bailly C, Laporte S, Lievre M; Investigators of INRPlus Study Group. Evaluation of a mobile electronic assistant to aid in fluindione prescription: the INRPlus cluster randomized trial. Thromb Res. 2014 May;133(5):756-61. doi: 10.1016/j.thromres.2014.02.003. Epub 2014 Feb 11. PubMed PMID: 24582071. |
